Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
暂无分享,去创建一个
J. J. Rosa | M. Gelb | P. Sigler | J. Browning | D. Scott | S. White | S. P. White | David Scott
[1] D. R. Holland,et al. The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution. , 1994, The Journal of biological chemistry.
[2] D. Clawson,et al. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution , 1991, Nature.
[3] P. Lawton,et al. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. , 1991, Journal of immunology.
[4] H. Arita,et al. Intracellular localization of group II phospholipase A2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formation. , 1991, Biochimica et biophysica acta.
[5] M. Gelb,et al. Interfacial catalysis: the mechanism of phospholipase A2 , 1990, Science.
[6] M. Gelb,et al. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue , 1990, Science.
[7] H. Arita,et al. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid , 1990, FEBS letters.
[8] K. H. Kalk,et al. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor , 1990, Nature.
[9] J. D. Clark,et al. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Gelb,et al. Kinetic and inhibition studies of phospholipase A2 with short-chain substrates and inhibitors. , 1990, Biochemistry.
[11] C. Schalkwijk,et al. Studies on the acyl-chain selectivity of cellular phospholipases A2. , 1990, Biochimica et biophysica acta.
[12] H. Tojo,et al. The primary structure of a membrane-associated phospholipase A2 from human spleen. , 1989, Biochemical and biophysical research communications.
[13] P. Vadas,et al. Multiple forms of phospholipase A2 in arthritic synovial fluid. , 1989, Journal of biochemistry.
[14] D. Smith,et al. Characterisation of soluble and cell associated phospholipase A2 from rheumatoid synovial fluid. , 1989, Annals of the rheumatic diseases.
[15] R. Kramer,et al. Structure and properties of a human non-pancreatic phospholipase A2. , 1989, The Journal of biological chemistry.
[16] W Pruzanski,et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. , 1989, The Journal of biological chemistry.
[17] G. Hughes,et al. Synovial fluid phospholipase A2s and inflammation. , 1989, Annals of the rheumatic diseases.
[18] H. Verheij,et al. The role of Asp‐49 and other conserved amino acids in phospholipases A2 and their importance for enzymatic activity , 1989, Journal of cellular biochemistry.
[19] A. Joachimiak,et al. Crystal structure of trp represser/operator complex at atomic resolution , 1988, Nature.
[20] K. Inoue,et al. Amino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid. , 1988, Journal of biochemistry.
[21] P. Fitzgerald. MERLOT, an integrated package of computer programs for the determination of crystal structures by molecular replacement , 1988 .
[22] M. Gelb,et al. Phosphonate-containing phospholipid analogues as tight-binding inhibitors of phospholipase-A2 , 1988 .
[23] E. Dennis. Regulation of Eicosanoid Production: Role of Phospholipases and Inhibitors , 1987, Bio/Technology.
[24] J. Musser,et al. Phospholipase A2: function and pharmacological regulation. , 1987, Biochemical pharmacology.
[25] B. Finzel. Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures , 1987 .
[26] M. Karplus,et al. Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.
[27] P. Vadas,et al. Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. , 1986, Journal of biochemistry.
[28] P. Vadas,et al. Role of secretory phospholipases A2 in the pathobiology of disease. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[29] P B Sigler,et al. The refined crystal structure of dimeric phospholipase A2 at 2.5 A. Access to a shielded catalytic center. , 1986 .
[30] P. Vadas,et al. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. , 1986, The Journal of investigative dermatology.
[31] F. Snyder. Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids , 1985, Medicinal research reviews.
[32] W G Hol,et al. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. , 1983, Journal of molecular biology.
[33] R. Irvine. How is the level of free arachidonic acid controlled in mammalian cells? , 1982, The Biochemical journal.
[34] W. Hol,et al. Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. , 1981, Journal of molecular biology.
[35] E. Dennis,et al. Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide. , 1978, The American journal of pathology.
[36] R. Verger,et al. Further studies of mode of action of lipolytic enzymes. , 1977, The Journal of biological chemistry.
[37] J. Vidal,et al. Zymogen-catalyzed hydrolysis of monomeric substrates and the presence of a recognition site for lipid-water interfaces in phospholipase A2. , 1974, Biochemistry.
[38] M. Lazdunski,et al. Zymogen-enzyme transformations. On the mechanism of activation of prophospholipase A. , 1972, European journal of biochemistry.
[39] R. A. Crowther,et al. A method of positioning a known molecule in an unknown crystal structure , 1967 .
[40] P. Sigler,et al. Facing up to membranes: structure/function relationships in phospholipases. , 1987, Cold Spring Harbor symposia on quantitative biology.